Chemical Structure (Lamotrigine 01)
Lamotrigine Tablet
Product Images NDC 71335-2071
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 71335-2071). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Lamotrigine 02)
Lamotrigine is a medication used to treat seizures in people with epilepsy and bipolar disorder.*
Figure 2 (Lamotrigine 03)
The text seems to be a comparison of the failure probability between a Placebo and a drug called LAMOTRIGINE, represented by a graph with axes representing probability (%). However, the graph itself is not included in the text provided.*
Image (Lamotrigine 04)
Image (Lamotrigine 05)
Image (Lamotrigine 06)
Image (Lamotrigine 07)
Label (Lbl713352071)
This is a description of a medication called Lamotrigine, which is a white (cream) round tablet produced by Taro Pharmaceutical Industries Ltd. The tablet has an engraving of "LMT" and the dose is 150mg. The medication is intended to be kept tightly closed at room temperature. The NDC number is 7133520711 and the expiry date is not provided.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
